本文選題：丹紅注射液 + 急性腦梗死　； 參考：《現(xiàn)代診斷與治療》2016年19期

【摘要】：選取2014年8月~2015年12月我院收治的68例急性腦梗死患者。隨機(jī)均分為對(duì)照組和觀察組各34例,兩組在抗血小板聚集、降脂及對(duì)癥等常規(guī)治療的基礎(chǔ)上,對(duì)照組給予丹參注射液,觀察組給予丹紅注射液,比較兩組臨床療效、神經(jīng)功能缺損程度評(píng)分及日常生活能力等情況。觀察組的有效率為91.48%,明顯高于對(duì)照組的70.59%,兩組比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)。治療后,觀察組的NIHSS評(píng)分與ADL評(píng)分明顯優(yōu)于對(duì)照組,兩組比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)。丹紅注射液治療急性腦梗死的療效確切,能夠明顯改善神經(jīng)功能缺損程度,提高患者的日常生活能力。
[Abstract]:From August 2014 to December 2015, 68 patients with acute cerebral infarction were selected. They were randomly divided into two groups: control group (n = 34) and observation group (n = 34). On the basis of antiplatelet aggregation, lipid lowering and symptomatic routine treatment, the control group was given Danshen injection, the observation group was given Danhong injection, and the two groups were treated with Danhong injection. Neurological impairment score and ability of daily living. The effective rate of the observation group was 91.48, which was significantly higher than that of the control group (70.59). The difference between the two groups was statistically significant (P 0.05). After treatment, the NIHSS score and ADL score in the observation group were significantly better than those in the control group, and the difference between the two groups was statistically significant (P 0.05). Danhong injection is effective in the treatment of acute cerebral infarction. It can obviously improve the degree of nerve function defect and improve the daily life ability of the patients.
【作者單位】： 重慶市九龍坡區(qū)第二人民醫(yī)院;
【分類號(hào)】：R743.33
，

本文編號(hào)：1829944